Watching brain spots closely instead of treating them right away, for people on cancer medicine that reaches the brain

Official title: PilotStudyAssessSafeActiveSurveillancApproachLocalThe Pa w/BrainMetsUndergoinCNSPenetratSystemicThe

Status: Recruiting. It is looking for patients now. Talk to your care team about whether it fits you.

The trial team last updated this record on .

The short version

This small study tests whether it is safe to watch cancer spots in the brain closely, instead of treating them right away.

Read our full plain-language summary

What the trial team says

This is a Pilot clinical trial determining the safety of an active surveillance approach to local therapy in subjects with brain metastases. These are subjects who are undergoing CNS-penetrating systemic therapy.

From the trial's own listing on ClinicalTrials.gov.

Key facts

Registry number
NCT07827001
Conditions studied
Brain Cancer, Brain Cancer Metastatic, Nervous System Cancer, CNS Cancer

Where it is running

This trial lists 1 site.

How to use this

Talk to your care team first. They know your history and can tell you whether this trial is worth your time.

Joining a trial is always your choice. A trial is a test, not a proven treatment. Being in one is not a promise that it will help you.

See the full listing on ClinicalTrials.gov

This page is built from the trial's listing on ClinicalTrials.gov, a service of the U.S. National Library of Medicine. That listing is the authority, and it may have changed since we last read it. We do not run this trial and we cannot enroll you in it.